Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro

Lymphatic Research and Biology

Volumn 8, Issue 3, 2010, Pages 155-164

  Chaitanya, G V ^a   Franks, S E ^a   Cromer, W ^a   Wells, S R ^a   Bienkowska, M ^a   Jennings, M H ^a   Ruddell, A ^b   Ando, T ^a   Wang, Y ^c   Gu, Y ^c   Sapp, M ^a   Mathis, J M ^a   Jordan, P A ^c   Minagar, A ^c   Alexander, J S ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b USA   (United States)

^c Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH VESSEL ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE; CELL PROLIFERATION; CYTOKINES; E-SELECTIN; ELECTRIC IMPEDANCE; ENDOTHELIUM, LYMPHATIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; INTERLEUKIN-1BETA; LYMPHANGIOGENESIS; MICE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77957571628     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2010.0004     Document Type: Article

References (71)

1. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-478.
2. Ali H, Haribabu B, Richardson RM, Snyderman R. Mechanisms of inflammation and leukocyte activation. Med Clin North Am 1997;81:1-28.
3. Granger DN, Kubes P. The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994;55:662-675.
4. Connor TJ, Harkin A, Kelly JP, Leonard BE. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment. Neuroimmunomodulation 2000;7:27-35.
5. Shigematsu T, Specian RD, Wolf RE, Grisham MB, Granger DN. MAdCAM mediates lymphocyte-endothelial cell adhesion in a murine model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2001;281: G1309-G1315.
6. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-953.
7. Makinen T, Norrmen C, Petrova TV. Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci 2007;64:1915-1929.
8. He Y, Rajantie I, Ilmonen M, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004;64:3737-3740.
9. Kerjaschki D, Huttary N, Raab I, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006;12:230-234.
10. Butler MG, Isogai S, Weinstein BM. Lymphatic development. Birth defects. Res C Embryo Today 2009;87:222-231.
11. Stacker SA, Williams RA, Achen MG. Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 2004;112:539-549.
12. Ji RC. Lymphatic endothelial cells, lymphedematous lymphangiogenesis, and molecular control of edema formation. Lymphat Res Biol 2008;6:123-137.
13. Schoppmann SF. Lymphangiogenesis, inflammation and metastasis. Anticancer Res 2005;25:4503-4511.
14. Cueni LN, Detmar M. The lymphatic system in health and disease. Lymphat Res Biol 2008;6:109-122.
15. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008;3:367-397.
16. Mouta C, Heroult M. Inflammatory triggers of lymphangiogenesis. Lymphat Res Biol 2003;1:201-218.
17. Geleff S, Schoppmann SF, Oberhuber G. Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch 2003;442:231-237.
18. Fogt F, Pascha TL, Zhang PJ, Gausas RE, Rahemtulla A, Zimmerman RL. Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. Int J Mol Med 2004;13:211-214.
19. Stokes KY, Clanton EC, Bowles KS, et al. The role of T-lymphocytes in hypercholesterolemia-induced leukocyteendothelial interactions. Microcirculation 2002;9:407-417.
20. Carpenter AC, Alexander JS. Endothelial PKC delta activation attenuates neutrophil transendothelial migration. Inflamm Res 2008;57:216-229.
21. Johnson LA, Clasper S, Holt AP, et al. An inflammationinduced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006;203:2763-2777.
22. Polzer K, D. Baeten D, A. Soleiman A, et al. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis 2008;67:1610-1616.
23. Rosell A, Arai K, Lok J, et al. Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab 2009;29:933-943.
24. Thapa D, Lee JS, Park MA, et al. Inhibitory effects of clotrimazole on TNF-alpha-induced adhesion molecule expression and angiogenesis. Arch Pharm Res 2009;32:593-603.
25. Shao X, Liu C, Influence of IFN-alpha and IFN-gamma on lymphangiogenesis. J Interferon. Cytokine Res 2006;26:568-574.
26. Ando T, Jordan P, Joh T, et al. Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC. Lymphat Res Biol 2005;3:105-115.
27. Cho WG, Albuquerque RJ, Kleinman ME, et al. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci USA 2009;106:7137-7142.
28. Carpenter A, Rassam A, Jennings MH, et al. Effects of ammonium tetrathiomolybdate, an oncolytic/angiolytic drug on the viability and proliferation of endothelial and tumor cells. Inflamm Res 2007;56:515-519.
29. Wells SR, Jennings MH, Rome C, Hadjivassiliou V, Papas KA, Alexander JS. Alpha-, gamma-and delta-tocopherols reduce inflammatory angiogenesis in human microvascular endothelial cells. J Nutr Biochem 2010;21:589-597.
30. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004;112:526-538.
31. Jackson DG. Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis. Cancer Treat Res 2007;135:39-53.
32. Goldman J, Rutkowski JM, Shields JD, et al. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J 2007;21:1003-1012.
33. Naldini A, Pucci A, Bernini C, Carraro F, Regulation of angiogenesis by Th1-and Th2-type cytokines. Curr Pharmaceut Design 2003;9:511-519.
34. Franchi A, Massi D, Santucci M, et al. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol 2006;208:439-445.
35. Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005;4:3-8.
36. Parr MB, Parr EL. Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunology 2000;99:540-545.
37. Goebel S, Huang M, Davis WC, et al. VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: Implications for inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2006;290: G648-G654.
38. Bjorndahl MA, Cao R, Burton JB, et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 2005;65:9261-9268.
39. Abdel-Malak NA, Harfouche R, Hussain SN. Transcriptome of angiopoietin 1-activated human umbilical vein endothelial cells. Endothelium 2007;14:285-302.
40. Brkovic A, Sirois MG. Vascular permeability induced by VEGF family members in vivo: Role of endogenous PAF and NO synthesis. J Cell Biochem 2007;100:727-737.
41. Lohela M, Saaristo A, Veikkola T, Alitalo K. Lymphangiogenic growth factors, receptors and therapies. Thromb Haemost 2003;90:167-184.
42. Krysiak O, Bretschneider A, Zhong E, et al. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF. Circ Res 2005;97:1253-1261.
43. Song M, Yang H, Yao S, et al. A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis. Biochem Biophys Res Commun 2007;357:924-930.
44. Ji RC, Eshita Y, Kato S, Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours. Int J Exp Pathol 2007;88:257-270.
45. Ando T, Langley RR, Wang Y, et al. Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion in vitro. BMC Physiol 2007;7:10.
46. Ando T, Jordan P, Wang Y, et al. MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro. Inflamm Bowel Dis 2005;11:258-264.
47. Oshima T, Jordan P, Grisham MB, et al. TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide. BMC Gastroenterol 2001;1:5.
48. Oshima T, Pavlick KP, Laroux FS, et al. Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. Am J Physiol Cell Physiol 2001;281:1096-C1105.
49. Oshima T, Laroux FS, Coe LL, et al. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res 2001;61:130-143.
50. Stannard AK, Khurana R, Evans IM, Sofra V, Holmes DI, Zachary I. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factoralpha. Arterioscler Thromb Vasc Biol 2007;27:494-502.
51. Sawa Y, Sugimoto Y, Ueki T, Ishikawa H, Sato A, Nagato T, Yoshida S. Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J Histochem Cytochem 2007;55:721-733.
52. Sawa Y, Ueki T, Hata M, et al. LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J Histochem Cytochem 2008;56:97-109.
53. Sasaki M, Mathis JM, Jennings MH, et al. Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. J Inflamm (Lond) 2005;2:13.
54. Sasaki M, Jordan P, Joh T, et al. Melatonin reduces TNF-a induced expression of MAdCAM-1 via inhibition of NF-kappaB. BMC Gastroenterol 2002;2:9.
55. Sasaki M, Ostanin D, Elrod JW, et al. TNF-alpha-induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent. Am J Physiol Cell Physiol 2003;284: C422-C428.
56. Park CC, Morel JC, Amin MA, et al. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001;167:1644-1653.
57. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003;100:2645-2650.
58. Kommineni VK, Nagineni CN, William A, Detrick B, Hooks JJ. IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1. Biochem Biophys Res Commun 2008;374:479-484.
59. Makinen T, Radams RH, Bailey J, et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005;19:397-410.
60. Pfaff D, Fiedler U, Augustin HG. Emerging roles of the angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking. J Leukoc Biol 2006;80:719-726.
61. Ganta VC, Cromer W, Mills GL, et al. Angiopoietin-2 in experimental colitis. Inflamm Bowel Dis 2010;16:1029-1039.
62. Kajiya K, Huggenberger R, Drinnenberg I, Ma B, Detmar M. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation. FASEB J 2008;22:530-537.
63. Middel P, Reich K, Polzien F, et al. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut 2001;49:795-803.
64. Middel P, Thelen P, Blaschke S, et al. Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease. Am J Pathol 2001;159:1751-1761.
65. Ryan TJ. Microcirculation in psoriasis: Blood vessels, lymphatics and tissue fluid. Pharmacol Ther 1980;10:27-64.
66. Gerli R, Alessandrini C. Initial lymph vessels of the skin and elastic fibres form an integral morphofunctional structure. Ital J Anat Embryol 1995;100:579-587.
67. Gerli R, Solito R, Weber E, Agliano M. Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 2000;33:148-157.
68. Hanley CA, Elias RM, Movat HZ, Johnston MG. Suppression of fluid pumping in isolated bovine mesenteric lymphatics by interleukin-1: Interaction with prostaglandin E2. Microvasc Res 1989;37:218-229.
69. Wu TF, MacNaughton WK, der Weid PY. Lymphatic vessel contractile activity and intestinal inflammation. Mem Inst Oswaldo Cruz 2005;100:107-110.
70. Muthuchamy M, Zawieja D. Molecular regulation of lymphatic contractility. Ann NY Acad Sci 2008;1131:89-99.
71. der Weid PY, Zawieja DC. Lymphatic smooth muscle: The motor unit of lymph drainage. Int J Biochem Cell Biol 2004;36:1147-1153.